亿胜生物科技（01061）于2026年9月10日发布公告，披露在香港联合交易所进行股份回购。公司当日回购普通股6万股，占回购前已发行股本约0.01062%，每股价格介乎2.06港元至2.08港元，此次回购涉资总额约12.42万港元。
本次回购完成后，公司已发行股份数为565,002,000股，库存股份数为2,004,000股，合计567,006,000股。公司表示，回购授权于2026年5月26日获得通过，可购回股份总数为56,700,600股，截至目前已在香港联交所及其他交易所累计回购2,004,000股，占授权通过当日发行股本约0.35344%。
公司确认回购事宜已遵守香港联合交易所有限公司证券上市规则及相关法例规定。公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.